Research
New Dartmouth Cancer Center study finds rural patients face delays in head and neck cancer treatment
The study focuses on whether patients begin radiation therapy within the recommended six-week window after surgery, a timeline known to improve survival for people with head and neck squamous cell carcinoma.
Study led by Dartmouth Cancer Center examines whether fewer bladder cancer procedures can safely improve patient experience
Reducing unnecessary procedures could lower discomfort and healthcare costs for thousands of patients without compromising quality of care.
Dartmouth Health-led trial finds outpatient procedure successful at maintaining GLP-1 weight loss after stopping medication
While most GLP-1 patients regain the weight they lost within 18 months of stopping the medication, 70% of participants who underwent duodenal mucosal resurfacing successfully kept the weight off.
Dartmouth Health research suggests increased hesitancy in post-COVID era toward standard childhood vaccinations, including HPV and Tdap
The findings of this paper suggest that the broader vaccine hesitancy that grew during the pandemic may have specifically impacted HPV vaccination.
Dartmouth Cancer Center researchers personalizing chemotherapy dosing for GI cancers
Research is currently exclusive to DCC
New study finds common blood pressure drug boosts cancer treatment
Dartmouth Cancer Center researchers find blood pressure medication telmisartan can significantly boost the cancer drug olaparib
Byrne Family Cancer Research Institute at Dartmouth Cancer Center tops $50 million goal
Partnership between Dartmouth Health, Dartmouth benefits patients across northern New England
Dartmouth Health physicians: AI can transform rural healthcare, but not without significant technology, access improvements
“From Bandwidth to Bedside — Bringing AI-Enabled Care to Rural America” published in New England Journal of Medicine
Dartmouth Cancer Center’s federal Comprehensive Cancer Center designation renewed through 2029
Renewed designation includes $13 million grant over five years
Diagnosing flesh-eating bacteria by injecting fluorescent dye? No, this isn’t a sci-fi blockbuster. Dartmouth Health-led research develops first-ever optical diagnostic tool for necrotizing soft-tissue infection
Necrotizing soft-tissue infections are easy to acquire, have mortality rates as high as 30%, and often aren’t caught until it’s too late.